Nutrien (NTR) Cash & Equivalents (2016 - 2026)

Nutrien's Cash & Equivalents history runs 11 years deep, the most recent figure standing at $777.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 13.18% year-over-year to $777.0 million; the TTM figure through Mar 2026 stood at $777.0 million (down 13.18% YoY), while the FY2025 annual figure was $701.0 million, down 17.82% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $777.0 million, up from $701.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.5 billion in Q1 2023, with the low at $496.0 million in Q1 2024.
• The 5-year median for Cash & Equivalents is $800.0 million (2022), against an average of $837.3 million.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents jumped 85.78% in 2022, then slumped 66.33% in 2024.
• Nutrien's Cash & Equivalents stood at $901.0 million in 2022, then rose by 4.44% to $941.0 million in 2023, then slipped by 9.35% to $853.0 million in 2024, then dropped by 17.82% to $701.0 million in 2025, then advanced by 10.84% to $777.0 million in 2026.
• Business Quant data shows NTR's Cash & Equivalents at $777.0 million in Q1 2026, $701.0 million in Q4 2025, and $624.0 million in Q3 2025.